Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Exportin-1 Connects Dynamic Transcription and Translation of Genotoxic Stress Genes in Diffuse Large B-Cell Lymphoma Patients

Rossella Marullo, MD PhD, Maria Revuelta, PhD, Nahuel Zamponi, PhD, Biljana Culjkovic, PhD, Shao Ning Yang, Haelee Ahn, Giorgio Inghirami, MD, Katherine L. B. Borden, PhD, Leandro Cerchietti, MD

Blood (2017) 130 (Supplement 1): 312.

https://doi.org/10.1182/blood.V130.Suppl_1.312.312

Published: 2017

Journal Articles

Ribavirin, an eIF4E Inhibitor, As a Potential Anti-Lymphoma Therapeutic - Preclinical and Early Clinical Data

Sarah C. Rutherford, MD, Eric Stewart, MD, Tharu M Fernando, MS, Biljana Culjkovic-Kraljacic, Katherine L. B. Borden, Koen van Besien, MD, Peter Martin, MD, Richard R Furman, MD, John P. Leonard, MD, Leandro Cerchietti, MD

Blood (2016) 128 (22): 3045.

https://doi.org/10.1182/blood.V128.22.3045.3045

Published: 2016

Journal Articles

Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas

Blood (2016) 127 (7): 858–868.

https://doi.org/10.1182/blood-2015-05-645069

Published: 2016

Includes: Supplemental data

Journal Articles

The Eukaryotic Translation Initiation Factor 4E (eIF4E) Has Oncogenic Functions and May Represent a New Therapeutic Target In Diffuse Large B Cell Lymphoma (DLBCL)

Biljana Culjkovic, PhD, Tharu Fernando, PhD student, ShaoNing Yang, MS, Ari M. Melnick, MD, Katherine LB Borden, PhD, Leandro Cerchietti, MD

Blood (2013) 122 (21): 3785.

https://doi.org/10.1182/blood.V122.21.3785.3785

Published: 2013

Journal Articles

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Hiba A Zahreddine, Biljana Culjkovic-Kraljacic, PhD, Sarit Assouline, MD, Abdellatif Amri, Patrick Gendron, M.Sc., Andrea A. Romeo, PhD, Stephen Morris, PhD, James Jaquith, PhD, Gregory Cormack, Eftihia Cocolakis, PhD, Julie Bergeron, MD, Leandro Cerchietti, MD, Brian Leber, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB. Borden, PhD

Blood (2013) 122 (21): 821.

https://doi.org/10.1182/blood.V122.21.821.821

Published: 2013

Journal Articles

Chemosensitization of Diffuse Large B Cell Lymphoma by Demethylating Nucleoside Analogues

Thomas Clozel, MD, ShaoNing Yang, Ms, Matthias Kormaksson, PhD, Rebecca Elstrom, MD, Aparna Vasanthakumar, BSc, MSc, PhD, Sarah Brennan, PhD, Biljana Culjkovic, PhD, Michael Leser, Peter Martin, MD, Katherine LB Borden, PhD, Y. Lynn Wang, MD, PhD, Shuhua Cheng, PhD, Wayne Tam, MD, PhD, Rita Shaknovich, MD/PhD, Amy Chadburn, MD, Lucy Godley, MD, PhD, John P. Leonard, MD, Ari Melnick, MD, Leandro Cerchietti, MD

Blood (2011) 118 (21): 1617.

https://doi.org/10.1182/blood.V118.21.1617.1617

Published: 2011

Journal Articles

The Eukaryotic Translation Initiation Factor eIF4E, a Recently Identified Therapeutic Target In AML, Is a Direct Transcriptional Target of NFkB

Fadi Hariri, Meztli Arguello, PhD, Biljana Culjkovic, PhD, Abdellatif Amri, Katherine Borden, PhD

Blood (2010) 116 (21): 3146.

https://doi.org/10.1182/blood.V116.21.3146.3146

Published: 2010

Journal Articles

Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.

Sarit E. Assouline, MD, Eftihia Cocolakis, PhD, Caroline Rousseau, PhD, Biljana Culjkovic, PhD, Nathalie Beslu, PhD, Abdellatif Amri, Stephen N. Caplan, MD, Brian Leber, MD, Denis-Claude Roy, MD, Katherine L. B. Borden, PhD, Wilson H. Miller, Jr., MD, PhD

Blood (2009) 114 (22): 2085.

https://doi.org/10.1182/blood.V114.22.2085.2085

Published: 2009

Journal Articles

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Sarit Assouline, Biljana Culjkovic, Eftihia Cocolakis, Caroline Rousseau, Nathalie Beslu, Abdellatif Amri, Stephen Caplan, Brian Leber, Denis-Claude Roy, Wilson H. Miller, Jr, Katherine L. B. Borden

Blood (2009) 114 (2): 257–260.

https://doi.org/10.1182/blood-2009-02-205153

Published: 2009

Includes: Supplemental data

NARROW

Exportin-1 Connects Dynamic Transcription and Translation of Genotoxic Stress Genes in Diffuse Large B-Cell Lymphoma Patients

Ribavirin, an eIF4E Inhibitor, As a Potential Anti-Lymphoma Therapeutic - Preclinical and Early Clinical Data

Combinatorial targeting of nuclear export and translation of RNA inhibits aggressive B-cell lymphomas

The Eukaryotic Translation Initiation Factor 4E (eIF4E) Has Oncogenic Functions and May Represent a New Therapeutic Target In Diffuse Large B Cell Lymphoma (DLBCL)

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Chemosensitization of Diffuse Large B Cell Lymphoma by Demethylating Nucleoside Analogues

The Eukaryotic Translation Initiation Factor eIF4E, a Recently Identified Therapeutic Target In AML, Is a Direct Transcriptional Target of NFkB

Targeting the Oncogene eIF4E with Ribavirin: A Novel Therapeutic Avenue in Acute Myeloid Leukemia.

Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only